Adjuvant Holdings Co.,Ltd. (TYO:4929)
Japan flag Japan · Delayed Price · Currency is JPY
745.00
-1.00 (-0.13%)
Apr 28, 2026, 3:30 PM JST

Adjuvant Holdings Revenue

In the fiscal year ending March 20, 2026, Adjuvant Holdings had annual revenue of 3.81B JPY, down -6.95%. Adjuvant Holdings had revenue of 692.00M in the quarter ending March 20, 2026, a decrease of -18.40%.

Revenue
3.81B
Revenue Growth
-6.95%
P/S Ratio
1.56
Revenue / Employee
30.75M
Employees
124
Market Cap
5.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 20, 20263.81B-285.00M-6.95%
Mar 20, 20254.10B-340.00M-7.66%
Mar 20, 20244.44B61.00M1.39%
Mar 20, 20234.38B-50.00M-1.13%
Mar 20, 20224.43B-458.00M-9.38%
Mar 20, 2021 Pro Pro Pro
Mar 20, 2020 Pro Pro Pro
Mar 20, 2019 Pro Pro Pro
Mar 20, 2018 Pro Pro Pro
Mar 20, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Almado 10.18B
HABA Laboratories,Inc. 12.17B
Premier Anti-Aging 14.97B
C'BON COSMETICS 9.22B
Sagami Rubber Industries 5.79B
AXXZIA 13.97B
Axas Holdings 12.48B
Liberta 10.03B
Revenue Rankings